Aralez pharmaceuticals inc. (ARLZ)
CashFlow / Yearly
Dec'17Dec'16
Operating Activities
Net loss

-125,205

-102,978

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

35,801

12,968

Amortization of debt issuance costs

106

84

Change in fair value of contingent consideration

35,725

750

Payment of contingent consideration

144

-4,368

Unrealized foreign currency transaction (gain) loss

48

100

(Gain) loss on sale of fixed assets

272

-200

Change in fair value of warrants liability

-24

-4,744

Share-based compensation expense

11,348

11,865

Benefit from deferred income taxes

1,066

-3,952

Changes in operating assets and liabilities:
Accounts receivable

-4,614

7,694

Inventory

1,811

819

Prepaid expenses and other current assets

1,241

-1,458

Accounts payable

14,694

-282

Accrued expenses and other liabilities

-2,349

5,442

Other assets

1,046

-

Other, net

-

297

Net cash provided by operating activities

-28,786

-83,731

Acquisitions of businesses, net of cash acquired

-

217,887

Purchases of property and equipment

1,822

4,166

Proceeds from sale of property and equipment

523

-

Other

215

715

Net cash used in investing activities

-1,514

-222,768

Proceeds from issuance of convertible debt

-

275,000

Proceeds from issuance of common stock

-

75,000

Payment of debt and equity issuance costs

-

778

Repayment of convertible note

-

3,922

Payment of contingent consideration

6,341

35

Proceeds from exercise of stock options / warrants

108

2,658

Payments related to settlement of stock awards

-

1,660

Net cash used in financing activities

-6,233

346,263

Net increase in cash and cash equivalents

-36,533

39,764

Effect of change in foreign exchange rates on cash and cash equivalents

482

363

Supplemental non-cash activities:
Fair value of assets acquired and liabilities assumed through acquisition of business (See Note 3)

-

115,136

Fair value of contingent consideration payable in connection with acquisition of business (See Note 3)

-

70,400

Non-cash additions to intangible assets (See Note 6)

-

221

Non-cash additions to property and equipment

-

2,828

Supplemental disclosure of cash flow information:
Income taxes paid

3,310

3,732

Interest paid

24,820

1,547